Abstract: Cancer of the lung system is arguably the second largest factor in the worldwide fatality explosion. It originates from smoking too much and tobacco use. Uncontrolled cell growth in the lung ...

A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...

Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...

Underwriters were given a 30-day option to purchase up to 1.74 million additional shares. ・Trevi is currently developing Haduvio, its treatment for chronic cough in patients with idiopathic pulmonary ...

Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...

Upright area-detector CT is equal to or better than supine ADCT in detecting the loss in lung function and assessing the severity of PPF.

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients ...

Columnist Kylene Henderson's husband, Donnie, had to pivot in many aspects of life due to PF, including changing his career.

A macrophage that has already fought off one infection does not return to a blank slate. It carries chemical scars, etched ...

Peer-reviewed study confirming strong predictive performance of patient-specific lung digital twins, validated against ...

A protein called PIEZO1, which is linked to mechanical stress, may play a key role in driving pulmonary fibrosis, a study ...